In 1919, physicist Theodor Kaluza hypothesized that extra dimensions might solve some outstanding problems in physics. And while we haven't found any evidence yet for anything outside our normal ...

Learn how to crochet a beautiful heart sweater that’s beginner-friendly and adjustable to any size. This tutorial covers step-by-step instructions, tips for custom sizing, and makes a perfect gift or ...

Learn how to crochet a beautiful rose in two sizes with detailed leaf accents! This step-by-step guide is perfect for beginners and experienced crocheters alike, ideal for decorations, gifts, or ...

Ignota Labs has harvested more assets for its drug candidate rehabilitation scheme, snapping up Kronos Bio’s clinical pipeline months after a series of setbacks drove the biotech off public markets. U ...

Kronos is a HOLD: TiO2 demand should rise, but KRO lacks operating leverage and control over key feedstocks to benefit from upside. KRO faces significant competition from Chinese producers, especially ...

Today (July 16) marks the 80th anniversary of the Trinity test, during which a team of U.S. scientists led by J. Robert Oppenheimer detonated the world’s first atomic bomb in the deserts of New Mexico ...

It’s a question Asa Chandler hasn’t stopped asking since he heard his old friend Tony Kronos was missing. The 40-year-old was last seen at his residence in the 1600 block of Eleonora Street in Eagle ...

(RTTNews) - Kronos Bio (KRON) has entered into a definitive merger agreement with Concentra Biosciences, LLC, whereby Concentra will acquire Kronos Bio for $0.57 in cash per share of Kronos Bio common ...

Performances in N.Y.C. Advertisement Supported by The venerable quartet returned to Zankel Hall with a typically eclectic program and a newfound emotional intensity. By Corinna da Fonseca-Wollheim The ...

It's not often that we find king-size beds in camper vans. The rig I'm discussing today has one, yet it still efficiently uses the rest of the space to pack much-needed amenities. Titan Vans is a ...

Kronos Bio, a San Mateo biotech company, is losing millions of dollars a month and recently had to discontinue its sole clinical-stage compound because of adverse side effects. Now, the company is ...